Stay updated on Dara-Thal-Dex in Relapse Myeloma Clinical Trial

Sign up to get notified when there's something new on the Dara-Thal-Dex in Relapse Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dara-Thal-Dex in Relapse Myeloma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Site revision label updated from v3.3.3 to v3.3.4; this minor change does not affect content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:40:09.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Footer shows Revision: v3.3.3 and the HHS Vulnerability Disclosure link was removed.
    Difference
    0.1%
    Check dated 2025-12-23T21:32:55.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision label updated from v3.2.0 to v3.3.2; no visible changes to study details, eligibility criteria, or endpoints. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:44:32.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The government funding/operating status notice was removed from the page. No clinical trial details or study information were changed.
    Difference
    0.4%
    Check dated 2025-11-18T06:54:22.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    No significant differences in the core Study Details page (NCT03143036) between the two screenshots; the study information appears unchanged aside from minor formatting. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:04:03.000Z thumbnail image
  8. Check
    106 days ago
    Change Detected
    Summary
    Major update to page content with new government status notice and NIH Clinical Center operating status, plus version bump to v3.2.0; removal of a specific genetic disease resource (Multiple myeloma) and downgrade from v3.1.0 to v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T05:36:39.000Z thumbnail image

Stay in the know with updates to Dara-Thal-Dex in Relapse Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dara-Thal-Dex in Relapse Myeloma Clinical Trial page.